Related Experiment Video
Updated: Aug 5, 2026
06:59
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Diagnostic approach to adults with hypoglycemic disorders
1Mayo Medical School, Rochester, Minnesota, USA.
Endocrinology and Metabolism Clinics of North America
|September 29, 1999
Summary
Diagnosing hypoglycemia is best during a spontaneous spell. If not possible, dynamic testing can induce symptoms for accurate diagnosis of hyperinsulinemia, even without meal relation.
Area of Science:
- Endocrinology
- Clinical Diagnostics
Background:
- Hypoglycemic disorders require accurate diagnosis for effective management.
- Spontaneous hypoglycemic episodes provide optimal diagnostic conditions.
- Neuroglycopenic symptoms necessitate further investigation regardless of meal timing.
Purpose of the Study:
- To outline optimal conditions and methods for diagnosing hypoglycemic disorders.
- To establish criteria for identifying hyperinsulinemia.
- To highlight the utility of specific dynamic tests in complex cases.
Main Methods:
- Confirmation of hypoglycemia during spontaneous symptomatic episodes.
- Utilization of dynamic testing to provoke hypoglycemic conditions when spontaneous spells are absent.
- Measurement of beta-cell polypeptide concentrations to establish hyperinsulinemia.
- Assaying plasma sulfonylureas using sensitive methods.
- Employing the selective arterial calcium test in challenging diagnostic scenarios.
Main Results:
- Spontaneous spells are the ideal diagnostic window for hypoglycemia.
- Dynamic testing is crucial for patients with a history of neuroglycopenic symptoms, irrespective of meal timing.
- Specific beta-cell polypeptide levels are definitive for diagnosing hyperinsulinemia.
- Sensitive assays are necessary for detecting sulfonylureas.
- The selective arterial calcium test proves valuable in complex diagnostic situations.
Conclusions:
- Accurate diagnosis of hypoglycemic disorders relies on timely confirmation during spontaneous episodes or via induced conditions.
- Established criteria for beta-cell polypeptides and sensitive sulfonylurea assays are essential for diagnosing hyperinsulinemia.
- Dynamic testing, including the selective arterial calcium test, aids in managing complex hypoglycemic cases.
More Related Videos
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...